1. Home
  2. TNXP vs ISPO Comparison

TNXP vs ISPO Comparison

Compare TNXP & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • ISPO
  • Stock Information
  • Founded
  • TNXP 2007
  • ISPO 2010
  • Country
  • TNXP United States
  • ISPO United States
  • Employees
  • TNXP N/A
  • ISPO N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • ISPO Blank Checks
  • Sector
  • TNXP Health Care
  • ISPO Finance
  • Exchange
  • TNXP Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • TNXP 19.5M
  • ISPO 39.0M
  • IPO Year
  • TNXP N/A
  • ISPO N/A
  • Fundamental
  • Price
  • TNXP $0.61
  • ISPO $3.36
  • Analyst Decision
  • TNXP Strong Buy
  • ISPO Buy
  • Analyst Count
  • TNXP 2
  • ISPO 2
  • Target Price
  • TNXP $53.50
  • ISPO $10.50
  • AVG Volume (30 Days)
  • TNXP 202.6M
  • ISPO 47.4K
  • Earning Date
  • TNXP 11-12-2024
  • ISPO 10-28-2024
  • Dividend Yield
  • TNXP N/A
  • ISPO N/A
  • EPS Growth
  • TNXP N/A
  • ISPO N/A
  • EPS
  • TNXP N/A
  • ISPO N/A
  • Revenue
  • TNXP $11,291,000.00
  • ISPO $287,451,000.00
  • Revenue This Year
  • TNXP $62.53
  • ISPO N/A
  • Revenue Next Year
  • TNXP $26.17
  • ISPO N/A
  • P/E Ratio
  • TNXP N/A
  • ISPO N/A
  • Revenue Growth
  • TNXP 183.05
  • ISPO N/A
  • 52 Week Low
  • TNXP $0.12
  • ISPO $3.11
  • 52 Week High
  • TNXP $14.08
  • ISPO $9.31
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 75.02
  • ISPO 44.01
  • Support Level
  • TNXP $0.32
  • ISPO $3.21
  • Resistance Level
  • TNXP $0.72
  • ISPO $3.74
  • Average True Range (ATR)
  • TNXP 0.15
  • ISPO 0.28
  • MACD
  • TNXP 0.04
  • ISPO -0.01
  • Stochastic Oscillator
  • TNXP 39.61
  • ISPO 19.23

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About ISPO Inspirato Incorporated

Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.

Share on Social Networks: